亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

Enhanced siRNA Delivery Using a Novel Peptide

详细技术说明

The given technology involves the use of a PTD-DRBD (peptide transduction domain-dsRNA binding protein) fusion peptide. DRBD binds siRNAs with high avidity independent of its sequence and allows PTD-mediated cellular uptake. PTD-DRBD mediated siRNA delivery occurs by a specialized process of macropinocytosis that prevents siRNA escape into the cytoplasm. UCSD researchers have tested this approach in 20+ cell types including human Embryonic Stem Cells, HUVECs, fibroblasts, keratinocytes and hematopoietic lineages and remarkably, siRNA responses were induced in the entire cell population in all 20 cell types in a rapid and non-cytotoxic fashion. In addition, PTD-DRBD siRNA delivery approach has been tested with great success in mouse models.

附加资料

Patent Number: US20120101045A1
Application Number: US13319326A
Inventor: Dowdy, Steven F. | Eguchi, Akiko
Priority Date: 7 May 2009
Priority Number: US20120101045A1
Application Date: 7 Nov 2011
Publication Date: 26 Apr 2012
IPC Current: A61K003817 | A61P003500 | C07K001400 | C07K001447 | C12N0005071
US Class: 5140193 | 435375 | 5140209 | 530300 | 530322 | 530358
Assignee Applicant: The Regents of the University of California
Title: TRANSDUCIBLE DELIVERY OF NUCLEIC ACIDS USING MODIFIED dsRNA BINDING DOMAINS
Usefulness: TRANSDUCIBLE DELIVERY OF NUCLEIC ACIDS USING MODIFIED dsRNA BINDING DOMAINS
Summary: For introducing an anionically charged nucleic acid molecule (preferably double stranded (ds)RNA) into cell; and for inhibiting expression of target nucleic acid in cell or subject, where target nucleic acid is nucleic acid that promotes cancerous phenotype (claimed) for treating cancer. Also useful for inducing RNA interference (RNAi) responses for manipulation of phenotypes for discovery research, and for treating viral diseases.
Novelty: New substantially purified polypeptide to treat e.g. cancer has specific amino acid length, and at least two histidine substitutions compared to specific nucleic acid binding polypeptides e.g. histone, protamine, or protein kinase R